Fixed-dose rivaroxaban is not associated with increased recurrent venous thromboembolism or major bleeding in patients with a high or low body weight
Autor: | Prins, Mh, Nisio, Md, Vedovati, MARIA CRISTINA, Riera Mestre, A, Mueller, K, Cohen, At, Wells, Ps, Beyer Westendorf, J, Brighton, Ta, Bounameaux, H, Schneider, J, Lensing, Aw |
---|---|
Rok vydání: | 2015 |
Databáze: | OpenAIRE |
Externí odkaz: |